FDA Inspection
AbbVie Clinical Pharmacology Research Unit (ACPRU)AbbVie Clinical Pharmacology Research Unit (ACPRU) – FDA Inspection, Jan 10, 2020
Record Details
This FDA Inspection record concerns AbbVie Clinical Pharmacology Research Unit (ACPRU), with an inspection on January 10, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- January 10, 2020
- Product Type
- Drugs
View Company Profile
ID · 21107ff7-956e-405e-b70f-3b8cb6da31e3
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1117577
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of AbbVie Clinical Pharmacology Research Unit (ACPRU)
1| Date | Classification | Office | Project area |
|---|---|---|---|
| December 1, 2017 | Not classified | Chicago District Office |
Other documents for AbbVie Clinical Pharmacology Research Unit (ACPRU)
- FDA Inspection 1036929 - 2017-12-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.